Cargando…
Advances in locoregional therapy for hepatocellular carcinoma combined with immunotherapy and targeted therapy
Locoregional therapies (LRTs) of hepatocellular carcinoma (HCC) represented by ablation and TACE has become the main means for the clinical treatment of unresectable HCC. Among these, TACE is used throughout the stage Ib to IIIb of HCC treatment. In recent years, immunotherapy led by immune checkpoi...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
KeAi Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562181/ https://www.ncbi.nlm.nih.gov/pubmed/34805958 http://dx.doi.org/10.1016/j.jimed.2021.05.002 |